These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 22406925)

  • 21. Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P) Suppresses Regulatory T Cell Recruitment in a Murine Glioma Model.
    Panek WK; Pituch KC; Miska J; Kim JW; Rashidi A; Kanojia D; Lopez-Rosas A; Han Y; Yu D; Chang CL; Kane JR; Zhang P; Cordero A; Lesniak MS
    Mol Neurobiol; 2019 Jul; 56(7):5032-5040. PubMed ID: 30460615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways.
    Skadborg SK; Maarup S; Draghi A; Borch A; Hendriksen S; Mundt F; Pedersen V; Mann M; Christensen IJ; Skjøth-Ramussen J; Yde CW; Kristensen BW; Poulsen HS; Hasselbalch B; Svane IM; Lassen U; Hadrup SR
    Cancer Immunol Res; 2024 Sep; 12(9):1202-1220. PubMed ID: 38885356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treg-cell depletion promotes chemokine production and accumulation of CXCR3(+) conventional T cells in intestinal tumors.
    Akeus P; Langenes V; Kristensen J; von Mentzer A; Sparwasser T; Raghavan S; Quiding-Järbrink M
    Eur J Immunol; 2015 Jun; 45(6):1654-66. PubMed ID: 25754875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma.
    Toker A; Nguyen LT; Stone SC; Yang SYC; Katz SR; Shaw PA; Clarke BA; Ghazarian D; Al-Habeeb A; Easson A; Leong WL; McCready DR; Reedijk M; Guidos CJ; Pugh TJ; Bernardini MQ; Ohashi PS
    Clin Cancer Res; 2018 Nov; 24(22):5685-5696. PubMed ID: 30065096
    [No Abstract]   [Full Text] [Related]  

  • 25. Upregulation of HLA-II related to LAG-3
    Guo W; Peng D; Liao Y; Lou L; Guo M; Li C; Yu W; Tian X; Wang G; Lv P; Zuo J; Shen H; Li Y
    Cancer Sci; 2024 May; 115(5):1388-1404. PubMed ID: 38480275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion of intratumoral regulatory T cells by human gastric cancer cells is dependent on transforming growth factor-β1.
    Lu X; Liu J; Li H; Li W; Wang X; Ma J; Tong Q; Wu K; Wang G
    J Surg Oncol; 2011 Nov; 104(6):571-7. PubMed ID: 21695703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity.
    Yano H; Andrews LP; Workman CJ; Vignali DAA
    Immunology; 2019 Jul; 157(3):232-247. PubMed ID: 31087644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of Glutamate Transport Enhances Treg Function That Promotes VEGF Blockade Resistance in Glioblastoma.
    Long Y; Tao H; Karachi A; Grippin AJ; Jin L; Chang YE; Zhang W; Dyson KA; Hou AY; Na M; Deleyrolle LP; Sayour EJ; Rahman M; Mitchell DA; Lin Z; Huang J
    Cancer Res; 2020 Feb; 80(3):499-509. PubMed ID: 31723000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells.
    Wang B; Li B; Dai Z; Ren S; Bai M; Wang Z; Li Z; Lin S; Wang Z; Huang N; Yang P; Liu M; Min W; Ma H
    Int J Biochem Cell Biol; 2014 Oct; 55():98-108. PubMed ID: 25168696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.
    Jordan JT; Sun W; Hussain SF; DeAngulo G; Prabhu SS; Heimberger AB
    Cancer Immunol Immunother; 2008 Jan; 57(1):123-31. PubMed ID: 17522861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
    Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
    Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of immunosuppressive mechanisms in a mouse glioma model.
    Ksendzovsky A; Feinstein D; Zengou R; Sharp A; Polak P; Lichtor T; Glick RP
    J Neurooncol; 2009 May; 93(1):107-14. PubMed ID: 19430886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4
    Kindlund B; Sjöling Å; Yakkala C; Adamsson J; Janzon A; Hansson LE; Hermansson M; Janson P; Winqvist O; Lundin SB
    Gastric Cancer; 2017 Jan; 20(1):116-125. PubMed ID: 26782287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
    Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
    J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
    Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
    J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased interleukin-10 production by ASC-deficient CD4+ T cells impairs bystander T-cell proliferation.
    Narayan S; Kolly L; So A; Busso N
    Immunology; 2011 Sep; 134(1):33-40. PubMed ID: 21718313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.
    Shibahara I; Saito R; Zhang R; Chonan M; Shoji T; Kanamori M; Sonoda Y; Kumabe T; Kanehira M; Kikuchi T; So T; Watanabe T; Takahashi H; Iwabuchi E; Tanaka Y; Shibahara Y; Sasano H; Ishii N; Tominaga T
    Mol Cancer; 2015 Feb; 14():41. PubMed ID: 25744203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma.
    Nummer D; Suri-Payer E; Schmitz-Winnenthal H; Bonertz A; Galindo L; Antolovich D; Koch M; Büchler M; Weitz J; Schirrmacher V; Beckhove P
    J Natl Cancer Inst; 2007 Aug; 99(15):1188-99. PubMed ID: 17652277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells.
    Wang HY; Peng G; Guo Z; Shevach EM; Wang RF
    J Immunol; 2005 Mar; 174(5):2661-70. PubMed ID: 15728473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor CD8 T cell responses in glioma patients are effectively suppressed by T follicular regulatory cells.
    Lu L; Sun J; Su H; Luo S; Chen J; Qiu S; Chi Y; Lin J; Xu X; Zheng D
    Exp Cell Res; 2021 Oct; 407(2):112808. PubMed ID: 34508744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.